Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and this week, it’s all about institutional money, cluster buys, and CEOs putting skin in the game.
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.
These are the 6 risk indicators I track for confirmation or divergence of the move in the S&P 500 — and right now, four are confirming the rally while two remain neutral, as the index...
